AU8479998A - Lyophilized fosphenytoin sodium for parenteral use - Google Patents

Lyophilized fosphenytoin sodium for parenteral use

Info

Publication number
AU8479998A
AU8479998A AU84799/98A AU8479998A AU8479998A AU 8479998 A AU8479998 A AU 8479998A AU 84799/98 A AU84799/98 A AU 84799/98A AU 8479998 A AU8479998 A AU 8479998A AU 8479998 A AU8479998 A AU 8479998A
Authority
AU
Australia
Prior art keywords
lyophilized
parenteral use
fosphenytoin sodium
fosphenytoin
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84799/98A
Inventor
Shahid Lodhi
Josephine Milstone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU8479998A publication Critical patent/AU8479998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU84799/98A 1997-07-22 1998-07-08 Lyophilized fosphenytoin sodium for parenteral use Abandoned AU8479998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5336497P 1997-07-22 1997-07-22
US60053364 1997-07-22
PCT/US1998/014234 WO1999004798A1 (en) 1997-07-22 1998-07-08 Lyophilized fosphenytoin sodium for parenteral use

Publications (1)

Publication Number Publication Date
AU8479998A true AU8479998A (en) 1999-02-16

Family

ID=21983716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84799/98A Abandoned AU8479998A (en) 1997-07-22 1998-07-08 Lyophilized fosphenytoin sodium for parenteral use

Country Status (2)

Country Link
AU (1) AU8479998A (en)
WO (1) WO1999004798A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3232078A1 (en) 2020-12-04 2022-06-09 Sichuan Credit Pharmaceutiical Co., Ltd Fosphenytoin sodium solid composition, lyophilization method, and use of fosphenytoin sodium solid composition
CN118161457A (en) * 2020-12-04 2024-06-11 四川科瑞德制药股份有限公司 Solid composition of fosphenytoin sodium, freeze-drying method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642316A (en) * 1985-05-20 1987-02-10 Warner-Lambert Company Parenteral phenytoin preparations
US4925860A (en) * 1987-08-05 1990-05-15 E. I. Du Pont De Nemours And Company Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester

Also Published As

Publication number Publication date
WO1999004798A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
AU9310298A (en) T-independent conjugate-vaccines
AU6936098A (en) Connector
AU3082299A (en) Structural connector
AU6362498A (en) Lockset
AU5670498A (en) Connector
AU7813598A (en) Betulinol derivatives
AU9001598A (en) Thiourea derivatives
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU8925398A (en) 3-descladinose 6-o-substituded erythromycin derivatives
AU1346199A (en) Connector
AU6932098A (en) Erythromycin derivatives
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU5515299A (en) 9-dialkylamino purinone derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU6115798A (en) Saponarin derivatives
AU1504899A (en) Erythromycin derivatives
AU8479998A (en) Lyophilized fosphenytoin sodium for parenteral use
AU2640999A (en) 1-azaindolizine derivatives
AU8736698A (en) Shale-stabilizing additives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase